Opendata, web and dolomites

Vaccinesurvey SIGNED

Monitor population immunity against vaccine preventable diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Vaccinesurvey project word cloud

Explore the words cloud of the Vaccinesurvey project. It provides you a very rough idea of what is the project "Vaccinesurvey" about.

hospitals    optimization    power    children    formidable    individuals    agencies    wireless    solution    co    largely    rapid    data    integrates    proven    optimal    unverified    ordinates    read    assay    vaccination    indicator    infected    microarray    capability    administrative    resource    proposes    preventable    rate    point    coupled    cross    simultaneously    levels    record    determinations    automation    private    pediatrician    innovative    outbreaks    interactive    receiving    integrity    software    childhood    vaccine    analytical    tool    quantify    collected    monitor    antibody    lateral    modeling    coverage    government    converts    inferred    diseases    generate    phones    healthcare    versus    components    emergency    translated    certification    countries    validate    made    temporal    profile    connectivity    individual    indirectly    programs    rates    multiplex    effort    protection    age    mainly    self    infection    communication    experimentally    unprecedented    vaccines    profiles    illnesses    basis    questioned    portable    discriminate    reactivity    smart    records    vaccinated    parallel    flow    utilized    performance    clinics    generating    monitoring    progress    spatial    donor    decrease    protein    population    district    concerning    doctors    situations    risk    small    funds    poor    regions    validity    difficult    immunization    allocate    additional    incentivize    antigens   

Project "Vaccinesurvey" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.vaccinesurveyproject.eu/
 Total cost 1˙053˙000 €
 EC max contribution 1˙053˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2014
 Funding Scheme MSCA-RISE
 Starting year 2015
 Duration (year-month-day) from 2015-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 328˙500.00
2    POLO D'INNOVAZIONE DI GENOMICA, GENETICA E BIOLOGIA SCARL IT (SIENA) participant 297˙000.00
3    GENIALIS D.O.O SI (LJUBLJANA) participant 220˙500.00
4    UNIVERSITA DEGLI STUDI DI PERUGIA IT (PERUGIA) participant 117˙000.00
5    UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA IT (ROMA) participant 90˙000.00
6    MICROTEST MATRICES LTD UK (LONDON) participant 0.00
7    MINISTERE DE LA SANTE BF (7003 Ouagadougou 03) partner 0.00

Map

 Project objective

In the recent years an unprecedented effort has been made to increase the rates of childhood immunization in resource poor countries. This has translated into an increased number of children receiving vaccines and a parallel decrease in the rate of illnesses from vaccine preventable diseases. However, in some regions it has proven difficult to achieve optimal levels of immunization mainly because of issues concerning communication, management and poor utilization of resources. Recent studies have questioned the validity of available vaccine coverage data and the way they are collected. Currently, both the progress of the vaccination programs and indirectly the level of protection in a population are inferred on the basis of administrative records. This largely unverified information is also utilized as performance indicator to allocate funds from government and donor agencies. Such self-certification practice does not incentivize the optimization of resources while it has been increasingly questioned in terms of its validity and integrity. We propose to develop and validate an innovative technical solution based on an assay system that integrates multiplex capability and analytical performance, to simultaneously quantify antibody levels against the major vaccine components, with both automation and wireless connectivity to produce spatial-temporal co-ordinates of individual determinations. The multiplex capability will facilitate the analysis of cross coverage monitoring while generating reactivity profiles against the different vaccine components to discriminate vaccinated versus infected individuals. Spatial temporal co-ordinates of assay results will be used to generate interactive data sets for modeling changes in the age-specific risk of infection and the risk of outbreaks. The proposed system represents a formidable tool of unprecedented power to monitor the progress of different vaccination programs and experimentally validate record-based coverage data. The consortium proposes to develop an additional implementation of the technology, a low-cost portable microarray solution for healthcare point of testing (i.e. private doctors or pediatrician clinics, small district hospitals, rapid control of real vaccination profile in emergency situations) that converts the protein microarray for the determination of antibody protection against vaccines antigens into a lateral flow protein microarray, which can be coupled with software application for Smart phones to read the results.

 Deliverables

List of deliverables.
Production of second Ethical Review report Documents, reports 2019-11-26 11:58:48
Production of interim disseminating knowledge plan Documents, reports 2019-11-26 11:58:47
Production of initial disseminating knowledge plans Documents, reports 2019-11-26 11:58:47
Nomination of the executive committee and work package leaders Documents, reports 2019-11-26 11:58:46
Production of first Ethical Review report Documents, reports 2019-11-26 11:58:47
Assay slides are produced and passed quality control Other 2019-11-26 11:58:46
Updating the VSO and the database Other 2019-11-26 11:58:49
Presentation of the technology alpha/beta version to stakeholders Documents, reports 2019-11-26 11:58:49
Engage stakeholders and community to collect opinion and feedback Documents, reports 2019-11-26 11:58:49
Mapping of Burkina Faso health care decision-making process Documents, reports 2019-11-26 11:58:47

Take a look to the deliverables list in detail:  detailed list of Vaccinesurvey deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VACCINESURVEY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VACCINESURVEY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

MAIL (2019)

Identifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy

Read More  

ENDORSE (2018)

Safe, Efficient and Integrated Indoor Robotic Fleet for Logistic Applications in Healthcare and Commercial Spaces

Read More